Although the mechanism by which insulin B10 aspart increases the risk of breast cancer is not clear, many studies (21–23) have proposed that this may be due to the high affinity of insulin B10 aspart for IGF-1R. The gene discussed is IGF1R; the disease is breast carcinoma.